Company Profiles

driven by the PitchBook Platform

Asepticys

Asepticys
2015 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$2.65M LATEST DEAL AMOUNT
$4.23M TOTAL AMOUNT RAISED
2 INVESTORS
Description

Developer of novel medical disinfection products designed to challenge modern medical disinfection. The company's disinfection products contain a unique combination of sterilizing agents, creating a multiple stressor environment that kills and deactivates pathogenic organisms across all microbial kingdoms and are effective across a broad spectrum of microbial pathogens and clinically beneficial in numerous medical and consumer healthcare applications, enabling healthcare providers to reduce hospital-acquired and consumer healthcare-related infection, as well as improve patient outcome via reduction of nosocomial infection in postsurgical treatment maintenance while in hospital.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Primary Office
201 Saint Charles Avenue
Suite 114, PMB 203
New Orleans, LA 70170
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Asepticys’s full profile, request a free trial.

Asepticys Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 11-Oct-2017 $2.65M $4.23M Completed Startup
1. Early Stage VC (Series A) 18-Mar-2016 00.000 00.000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Asepticys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table request access »

Asepticys Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
John T. Siegel Revocable Trust Other Minority 000 0000 000000 0

You’re viewing 2 of 2 investors.

Asepticys Executive Team (3)

Name Title Board
Seat
Contact
Info
Chad Roy Ph.D Co-Chief Executive Officer & Board Member
Todd Rands Co-Chief Executive Officer
Robert Reimers Ph.D Director

You’re viewing 3 of 3 executives.

Asepticys Board Members (3)

Name Representing Role Since Contact
Info
Chad Roy Ph.D Asepticys Co-Chief Executive Officer & Board Member 000 0000
Fredric Eshelman Self Board Member 000 0000
Tom Crawford Self Board Member 000 0000

You’re viewing 3 of 3 board members.